Palbociclib Prevents CDK4/6 Dependent-Myeloproliferation and Myelofibrosis

被引：0
|
作者：
Duparc, Helene
Muller, Delphine
Antony-Debre, Ileana
Marty, Caroline
Debili, Najet
Villeval, Jean-Luc
Plo, Isabelle
Vainchenker, William
Gilles, Laure
Raslova, Hana
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141092
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clarithromycin Interactions with Palbociclib (CDK4/6 Inhibitor)
    Hu, Xiuqiong
    Yang, Wei
    Liu, Lanjie
    Qin, Hua
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (07): : 1698 - 1707
  • [2] PALBOCICLIB Cyclin CDK4/CDK6 Inhibitor Oncolytic
    Haddley, K.
    DRUGS OF THE FUTURE, 2013, 38 (11) : 745 - 755
  • [3] Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy
    van Aken, Evert S. M.
    Beeker, Aart
    Houtenbos, Ilse
    Pos, Floris J.
    Linn, Sabine C.
    Elkhuizen, Paula H. M.
    de Jong, Monique C.
    CANCER REPORTS, 2022, 5 (02)
  • [4] Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer
    Chen, Fengquan
    Liu, Chunxi
    Zhang, Jian
    Xu, Wenfang
    Zhang, Yingjie
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (09) : 1241 - 1251
  • [5] 新型CDK4/6抑制剂palbociclib
    范丽萍
    焦园园
    郭子寒
    张艳华
    中国新药杂志, 2015, (19) : 2161 - 2163+2202
  • [6] TARGETED COMBINATION THERAPY WITH CDK4/6 INHIBITOR PALBOCICLIB IN AML
    Uras, I.
    Valent, P.
    Sexl, V.
    HAEMATOLOGICA, 2017, 102 : 207 - 208
  • [7] Factors that limit delivery of Cdk4/6 inhibitor palbociclib to GBM
    Parrish, K.
    Pokorny, J.
    Mittapalli, R.
    Bakken, K.
    Sarkaria, J.
    Elmquist, W.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 86 - 86
  • [8] 首个CDK4/6抑制剂新药——Palbociclib
    康建磊
    王彦明
    临床药物治疗杂志, 2016, 14 (04) : 85 - 88
  • [9] Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
    Guillaume, Zoe
    Medioni, Jacques
    Lillo-Lelouet, Agnes
    Marret, Gregoire
    Oudard, Stephane
    Simonaggio, Audrey
    CLINICAL BREAST CANCER, 2020, 20 (02) : E192 - E195
  • [10] Development and characterization of a novel CDK4/6 inhibitor for the treatment of CDK4/6 dependent cancers
    O'Brien, Neil A.
    McDermott, Martina S.
    O'Boyle, Brendan M.
    Hilf, Justin A.
    Loson, Oliver
    Chau, Kevin
    Jia, Weiping
    Kamranpour, Naeimeh
    Luo, Tong
    Ayala, Raul
    Issakhanian, Shawnt
    Glaspy, John A.
    Stoltz, Brian M.
    Slamon, Dennis J.
    CANCER RESEARCH, 2023, 83 (07)
12345